MedX Health Corp. MDXHF
0.03
0.00
0.00%
as of 24 Sep
- Market cap
- $103.2M
- P/E
- 0.0×
Follow MDXHF
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.00 | 40.22 | 8.75 | 33.55 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
0.00 | (29.49) | (3.70) | (22.36) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
7.08 | 48.01 | 12.29 | 39.04 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(1.06) | (7.84) | (1.56) | (5.23) | |
EV/FCF |
(0.48) | (3.53) | (0.79) | (2.82) | |
Quick Ratio |
0.06 | 0.06 | 0.01 | 0.02 | |
Current Ratio |
0.11 | 0.10 | 0.04 | 0.04 | |
Net Debt/EBITDA |
(3.66) | (4.65) | (1.32) | (3.28) | |
Debt/Assets |
352.09% | 322.96% | 241.50% | 497.19% | |
Debt/Equity |
(0.40) | (0.40) | (0.17) | (0.32) | |
Asset Turnover |
0.51 | 0.48 | 0.59 | 0.79 | |
Operating CF/Net income |
1.07 | 0.55 | 0.53 | 0.66 | |
Capex/Depreciation |
(42.33) | (27.98) | (0.14) | (31.21) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
142.03% | 92.67% | 90.32% | 79.55% | |
Selling, General and Administrative Expense of Revenue |
930.63% | 584.42% | 728.23% | 470.14% | |
Intangible Assets out of Total Assets |
103.08 | 85.99 | 155.90 | 177.24 | |
Share Based Compensation of Revenue |
47.34% | 42.67% | 121.77% | 8.95% | |
Graham Net Nets |
0.00 | (0.50) | (2.42) | (0.54) | |
Graham Number |
0.08 | 0.09 | 0.09 | 0.08 | |
Earnings Yield |
0.00% | (26.80%) | (152.00%) | (34.50%) | |
Free Cash Flow Yield |
0.00% | (33.86%) | (178.45%) | (41.33%) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
(0.02) | (0.02) | (0.02) | (0.02) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.02) | (0.02) | (0.02) | (0.02) | |
Free Cash Flow |
(1.38) | (0.77) | (0.80) | (0.95) | |
Working Capital |
(5.49) | (6.37) | (7.00) | (6.00) | |
Capital Expenditures |
(0.36) | (0.26) | 0.00 | (0.36) | |
Net Current Asset Value |
(6.37) | (7.50) | (7.18) | (7.08) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
5.69 | 2.68 | 0.02 | 2.79 | |
Net Profit Margin |
(1,486.41%) | (948.78%) | (1,519.05%) | (687.89%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.24 | 0.28 | 0.15 | 0.15 | |
Average Payables |
1.84 | 1.94 | 1.75 | 1.89 | |
Average Inventory |
0.29 | 0.29 | 0.20 | 0.19 | |
Average Assets |
0.67 | 0.78 | 0.57 | 0.49 | |
Average Common Equity |
(6.24) | (6.93) | (6.60) | (6.75) |
Columns are period end dates